ID: MRFR/HC/7339-HCR | 90 Pages | Published By Kinjoll Dey on March 2023
Facial rejuvenation market is expected to reach USD26.36 Million at 20.65.7.10% CAGR by 2030.
$ 26.36 Billion
7.10%
North America
2022-2030
Market Synopsis
Facial rejuvenation market is expected to reach USD at 7.10% CAGR by 2030. Facial rejuvenation is a type of cosmetic treatment that uses non-invasive or minimally invasive procedures to restore the skin elasticity and improve the appearance of the skin. Growing demand for non-invasive aesthetic procedures, technological advancements by market players and changing lifestyle of the urban population are the key factors that are expected to drive the market growth. Moreover, the rising demand for quick results & shorter treatment durations and increasing popularity & awareness regarding facial rejuvenation are also expected to boost market growth.
Facial Rejuvenation Market Influencer
The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures.
Facial Rejuvenation Market Drivers
Facial Rejuvenation Market Restraints
Facial Rejuvenation Market Segmentation
By Product Type
By End-User
By Region
Facial Rejuvenation Market Key Players
Report Attribute/Metric | Details |
Market Size | USD 26.36 Billion |
CAGR | 7.10% (2022-2030) |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product Type and By End-User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Allergan (Ireland), Merz Pharma (Germany), Galderma (Switzerland), Lumenis (US), Revance (US), Contura Ltd (US), Anika Therapeutics, Inc. (US), Fibrocell Science, Inc. (US), Cynosure, A Hologic Company (US), Daewoong Co. Ltd (South Korea), Sinclair Pharma (UK), Teoxane Laboratories (Switzerland), Suneva Medical (US), Solta Medical, a Subsidiary of Bausch Health Companies (US), and SciVision Biotech Inc. (Taiwan). |
Key Market Opportunities | The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures |
Key Market Drivers | Cost-effective alternative to cosmetic surgeries. Rising demand for non-invasive aesthetic procedures. Increasing R&D expenditure by companies to develop advanced treatments |
The requirement for non-invasive aesthetic procedures is estimated to promote the global market.
By 2030, the market is anticipated to observe 7.10% CAGR in the impending period.
An income of USD 26.36 Billion is to be expected to spur the market.
The Americas regional market is estimated to gain a leadership position in the forecast period.
Anika Therapeutics, Inc. (US), Galderma (Switzerland), Revance (US), Contura Ltd (US), Lumenis (US), and Fibrocell Science, Inc. (US) are the frontrunners in the market.